AdaptHealth (AHCO) Cash from Investing Activities (2018 - 2026)
AdaptHealth has reported Cash from Investing Activities over the past 8 years, most recently at -$124.5 million for Q4 2025.
- For Q4 2025, Cash from Investing Activities fell 43.28% year-over-year to -$124.5 million; the TTM value through Dec 2025 reached -$303.2 million, up 2.28%, while the annual FY2025 figure was -$303.2 million, 2.28% up from the prior year.
- Cash from Investing Activities for Q4 2025 was -$124.5 million at AdaptHealth, down from -$92.7 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $9.6 million in Q2 2025 and troughed at -$1.2 billion in Q1 2021.
- A 5-year average of -$160.3 million and a median of -$91.6 million in 2023 define the central range for Cash from Investing Activities.
- Biggest five-year swings in Cash from Investing Activities: crashed 2536.4% in 2021 and later soared 111.82% in 2025.
- Year by year, Cash from Investing Activities stood at -$266.2 million in 2021, then skyrocketed by 45.24% to -$145.8 million in 2022, then surged by 37.98% to -$90.4 million in 2023, then grew by 3.92% to -$86.9 million in 2024, then tumbled by 43.28% to -$124.5 million in 2025.
- Business Quant data shows Cash from Investing Activities for AHCO at -$124.5 million in Q4 2025, -$92.7 million in Q3 2025, and $9.6 million in Q2 2025.